Characterization of NT-proBNP in a large cohort of COVID-19 patients.

ABSTRACT:

Aims

Extensive research regarding the association of troponin and prognosis in coronavirus disease 2019 (COVID-19) has been performed. However, data regarding natriuretic peptides are scarce. N-terminal pro B-type natriuretic peptide (NT-proBNP) reflects haemodynamic stress and has proven useful for risk stratification in heart failure (HF) and other conditions such as pulmonary embolism and pneumonia. We aimed to adequately characterize NT-proBNP concentrations using a large cohort of patients with COVID-19, and to investigate its association with prognosis.

Methods and results

Consecutive patients with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and available NT-proBNP determinations, from March 1st to April 20th, 2020 who completed at

SUBMITTER: Caro-Codon J 

PROVIDER: S-EPMC8013330 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature